Ryan W. Huey, MD, discusses challenges faced with immunotherapy in hepatocellular carcinoma.
Ryan W. Huey, MD
Advertisement
Articles by Ryan W. Huey, MD
Ryan W. Huey, MD, assistant professor, Department of Gastrointestinal Medical Oncology, The University of Texas MD Anderson Cancer Center, discusses the landscape of hepatocellular carcinoma (HCC).
Ryan W. Huey, MD, discusses potential sequencing options with sorafenib among novel combination strategies in hepatocellular carcinoma.
Advertisement
Latest Updated Articles
Dr. Huey on Challenges Faced With Immunotherapy in HCCJune 19th 2020
Dr. Huey on Sequencing Sorafenib Among Novel Combos in HCCMarch 12th 2020
Dr. Huey on Navigating the Landscape of HCCApril 23rd 2020
Advertisement
Advertisement
Trending on OncLive
1
ctDNA Status Has Strong Prognostic Value, Outperforming pCR Status, in Early TNBC
2
The OncFive: Top Oncology Articles for the Week of 5/31
3
From Toilet Cleaner to Thoracic Oncologist and Patient: How Ross Camidge Built a Life Worth Loving
4
CELMoDs and Bispecifics Break Through Across Lymphomas and Leukemias at EHA 2026
5